Moderate Evidence (L3-L4)
Candidates with preliminary evidence that require further validation
Criteria
| Level | Definition | Clinical meaning |
|---|---|---|
| L3 | Observational studies / large case series | Preliminary support; needs further validation |
| L4 | Preclinical / mechanistic studies | Theoretical support; far from clinical use |
L3 (36 drugs)
| Drug | Indications | Link |
|---|---|---|
| Abatacept | 7 | View report |
| Acitretin | 4 | View report |
| Alprazolam | 2 | View report |
| Beclomethasone Dipropionate | 1 | View report |
| Calcipotriol | 10 | View report |
| Cilastatin | 9 | View report |
| Clonazepam | 3 | View report |
| Cyclobenzaprine | 3 | View report |
| Daunorubicin | 10 | View report |
| Dupilumab | 9 | View report |
| Eltrombopag | 1 | View report |
| Etafedrine | 1 | View report |
| Everolimus | 8 | View report |
| Flecainide | 9 | View report |
| Fluoxetine | 8 | View report |
| Idelalisib | 6 | View report |
| Imipramine | 7 | View report |
| Lenvatinib | 5 | View report |
| Magnesium Sulfate | 8 | View report |
| Medroxyprogesterone Acetate | 6 | View report |
| Mercaptopurine | 8 | View report |
| Micafungin | 1 | View report |
| Nitroglycerin | 4 | View report |
| Oxazepam | 1 | View report |
| Pazopanib | 6 | View report |
| Pimozide | 10 | View report |
| Procarbazine | 5 | View report |
| Ropinirole | 10 | View report |
| Ropivacaine | 4 | View report |
| Sofosbuvir | 8 | View report |
| Tocilizumab | 5 | View report |
| Trazodone | 9 | View report |
| Trimebutine | 2 | View report |
| Tryptophan | 8 | View report |
| Vandetanib | 10 | View report |
| Xylometazoline | 1 | View report |
L4 (62 drugs)
| Drug | Indications | Link |
|---|---|---|
| Aminophylline | 9 | View report |
| Anagrelide | 2 | View report |
| Arginine | 1 | View report |
| Atazanavir | 4 | View report |
| Atropine | 2 | View report |
| Beta Carotene | 10 | View report |
| Betamethasone | 7 | View report |
| Bicalutamide | 10 | View report |
| Bosentan | 8 | View report |
| Buprenorphine | 6 | View report |
| Chloroprocaine | 1 | View report |
| Cortisone Acetate | 8 | View report |
| Cyproterone Acetate | 9 | View report |
| Cysteine | 7 | View report |
| Cytarabine | 9 | View report |
| Deferasirox | 5 | View report |
| Deferiprone | 8 | View report |
| Desvenlafaxine | 8 | View report |
| Doxazosin | 2 | View report |
| Dronedarone | 9 | View report |
| Efavirenz | 3 | View report |
| Entecavir | 9 | View report |
| Ephedrine | 2 | View report |
| Ethanol | 2 | View report |
| Febuxostat | 3 | View report |
| Fulvestrant | 10 | View report |
| Gemfibrozil | 9 | View report |
| Glutamic Acid | 4 | View report |
| Hydrocodone | 1 | View report |
| Ketoconazole | 1 | View report |
| Lomustine | 3 | View report |
| Lopinavir | 3 | View report |
| Meropenem | 7 | View report |
| Methadone | 7 | View report |
| Miconazole | 1 | View report |
| Minoxidil | 10 | View report |
| Nabilone | 9 | View report |
| Nevirapine | 3 | View report |
| Nitroprusside | 9 | View report |
| Norepinephrine | 3 | View report |
| Oxcarbazepine | 1 | View report |
| Palonosetron | 4 | View report |
| Papaverine | 10 | View report |
| Phenylalanine | 2 | View report |
| Phenylephrine | 2 | View report |
| Polymyxin B | 2 | View report |
| Potassium Chloride | 1 | View report |
| Pravastatin | 6 | View report |
| Progesterone | 6 | View report |
| Propylthiouracil | 2 | View report |
| Ribociclib | 4 | View report |
| Rifampicin | 10 | View report |
| Rilpivirine | 3 | View report |
| Selenium | 1 | View report |
| Streptomycin | 10 | View report |
| Tenofovir Alafenamide | 3 | View report |
| Tobramycin | 10 | View report |
| Triamcinolone | 8 | View report |
| Valine | 10 | View report |
| Velpatasvir | 10 | View report |
| Vinblastine | 10 | View report |
| Zinc Oxide | 5 | View report |
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)